Current gene therapy models are limited by inadequate vector delivery. Incr
eases in microvascular permeability have been shown to improve adenovirus-m
ediated gone transfer to ex vivo and in vivo models. We explored the intrac
ellular mechanism underlying the permeabilizing effects of vascular endothe
lial growth factor (VEGF). Using an cs vivo model of coronary perfusion in
rabbits. rue found a dose-response relationship between VEGF and the effici
ency of adenoviral gene transfer. Inhibitors of nitric oxide synthase and g
uanylate cyclase prevented the VEGF effect, and analogues of nitric oxide a
nd cGMP mimicked the effect. Co-administration of phosphodiesterase 5 inhib
itors and VEGF caused a synergistic increase in gene delivery. These result
s can be readily applied to existing models to further optimize vector deli
very for gene therapy. (C) 2001 Academic Press.